Novo Nordisk hit by slowing Ozempic sales, Tesla shareholders sue Musk over Robotaxi - Stock market news and latest business ...

Nonetheless, it might not be entirely bleak for Tesla, as a series of new catalysts could be rejuvenating the stock’s ...

Tesla shares are at the cusp of a critical chart point, according to Fundstrat technical strategist Mark Newton. His setup is simple. A daily close above the $338 mark will potentially open the door ...